Knowledge Structure and Trends of Vitiligo From 2002 to 2023: A Bibliometric Analysis
Keywords:
vitiligo, bibliometrics, unfolded protein response, janus kinases , CXCL10Abstract
Introduction: Vitiligo is a common acquired depigmenting dermatosis resulting from a loss of epidermal melanocytes. The academic attention to vitiligo has gradually increased over the past two decades.
Objective: We aimed to explore the current research structure and trends of vitiligo.
Methods: Publications about vitiligo from the Web of Science Core Collection (WoSCC) database were searched. VOSviewer, CiteSpace, GraphPad Prism 8, ArcGIS, and Charticulator were implemented for data description and visual analysis.
Results: A total of 3,037 publications authored by 10,993 individuals from 2,753 institutions across 88 countries/regions were collected. These publications were published in 616 journals and cited a total of 39,433 references. China was the most productive country. Cairo University and Ezzedine Khaled were the most prolific institution and author, respectively. Additionally, the British Journal of Dermatology stood out as the journal with the highest number of publications. According to the analysis of keywords and references, “quality of life,” “depression,” and “validation” were hotspots in terms of clinical characteristics, while “prevalence”, “comorbidity,” “association,” and “immunotherapy” gained more research interest with respect to epidemiology and genetics. The frontiers of pathogenesis focused on “unfolded protein response,” “migration,” “biomarkers,” and “CXCL10.” As far as treatment is concerned, there was increasing attention to “janus kinase inhibitor,” “fractional carbon dioxide laser,” “platelet-rich plasma,” and “5-fluorouracil.”
Conclusion: The bibliometric analysis elucidates the foundational knowledge structure on research forces and unveiled the hotspots and frontiers, aiding researchers in gaining a deeper comprehension of the future development trends in the field of vitiligo.
References
Taïeb A, Picardo M. The definition and assessment of vitiligo: a consensus report of the Vitiligo European Task Force. Pigment Cell Res. 2007;20(1):27-35. DOI: 10.1111/j.1600-0749.2006.00355.x. PMID: 17250545.
Alikhan A, Felsten LM, Daly M, Petronic-Rosic V. Vitiligo: a comprehensive overview Part I. Introduction, epidemiology, quality of life, diagnosis, differential diagnosis, associations, histopathology, etiology, and work-up. J Am Acad Dermatol. 2011;65(3):473-491. DOI: 10.1016/j.jaad.2010.11.061. PMID: 21839315.
Krüger C, Schallreuter KU. A review of the worldwide prevalence of vitiligo in children/adolescents and adults. Int J Dermatol. 2012;51(10):1206-1212. DOI: 10.1111/j.1365-4632.2011.05377.x. PMID: 22458952.
Yan W-T, Lu S, Yang Y-D, et al. Research trends, hot spots and prospects for necroptosis in the field of neuroscience. Neural Regen Res. 2021;16(8):1628-1637. DOI: 10.4103/1673-5374.303032. PMID: 33433494.
Ninkov A, Frank JR, Maggio LA. Bibliometrics: Methods for studying academic publishing. Perspect Med Educ. 2022;11(3):173-176. DOI: 10.1007/s40037-021-00695-4. PMID: 34914027.
Şenel E. The Depigmented Literature: A Holistic Analysis of Global Vitiligo Publications between 1975 and 2017. Indian J Dermatol. 2020;65(5):388-395. DOI: 10.4103/ijd.IJD_390_18. PMID: 33165419.
Falagas ME, Pitsouni EI, Malietzis GA, Pappas G. Comparison of PubMed, Scopus, Web of Science, and Google Scholar: strengths and weaknesses. FASEB J. 2008;22(2):338-342. DOI: 10.1096/fj.07-9492LSF. PMID: 17884971.
Marzi G, Caputo A, Garces E, Dabic M. A Three Decade Mixed-Method Bibliometric Investigation of the IEEE Transactions on Engineering Management. IEEE Trans Eng Manag. 2020 Feb;67(1):4-17. DOI: 10.1109/tem.2018.2870648.
Zyoud SeH. Global toxocariasis research trends from 1932 to 2015: a bibliometric analysis. Health Res Policy Syst. 2017;15(1):14. DOI: 10.1186/s12961-017-0178-8. PMID: 28231792.
van Eck NJ, Waltman L. Software survey: VOSviewer, a computer program for bibliometric mapping. Scientometrics. 2010;84(2):523-538. DOI: 10.1007/s11192-009-0146-3. PMID: 20585380.
Chen CM. CiteSpace II: Detecting and visualizing emerging trends and transient patterns in scientific literature. J Am Soc Inf Sci Technol. 2006;57(3):359-377. DOI:10.1002/asi.20317
Chen CM. Science Mapping: A Systematic Review of the Literature. J Data Inf Sci.2017;2(2):1-40. DOI: 10.1515/jdis-2017-0006.
Chen C, Leydesdorff L. Patterns of Connections and Movements in Dual-Map Overlays: A New Method of Publication Portfolio Analysis. J Assoc Inf Sci Technol. 2014;65(2):334-351. DOI: 10.1002/asi.22968.
Rosmarin D, Passeron T, Pandya AG, et al. Two Phase 3, Randomized, Controlled Trials of Ruxolitinib Cream for Vitiligo. N Engl J Med. 2022;387(16):1445-1455. DOI: 10.1056/NEJMoa2118828. PMID: 36260792.
Ezzedine K, Peeva E, Yamaguchi Y, et al. Efficacy and safety of oral ritlecitinib for the treatment of active nonsegmental vitiligo: A randomized phase 2b clinical trial. J Am Acad Dermatol. 2023;88(2):395-403. DOI:10.1016/j.jaad.2022.11.005. PMID: 36370907
Krüger C, Schallreuter KU. Stigmatisation, Avoidance Behaviour and Difficulties in Coping are Common Among Adult Patients with Vitiligo. Acta Derm Venereol. 2015;95(5):553-558. DOI: 10.2340/00015555-1981. PMID: 25269389.
Lai YC, Yew YW, Kennedy C, Schwartz RA. Vitiligo and depression: a systematic review and meta-analysis of observational studies. Br J Dermatol. 2017;177(3):708-718. DOI: 10.1111/bjd.15199. PMID: 27878819.
Ezzedine K, Eleftheriadou V, Jones H, et al. Psychosocial Effects of Vitiligo: A Systematic Literature Review. Am J Clin Dermatol. 2021;22(6):757-774. DOI: 10.1007/s40257-021-00631-6. PMID: 34554406.
Bibeau K, Ezzedine K, Harris JE, et al. Mental Health and Psychosocial Quality-of-Life Burden Among Patients With Vitiligo: Findings From the Global VALIANT Study. JAMA Dermatol. 2023;159(10):1124-1128. DOI:10.1001/jamadermatol.2023.2787. PMID: 37647073.
Finlay AY, Khan GK. Dermatology Life Quality Index (DLQI)--a simple practical measure for routine clinical use. Clin Exp Dermatol. 1994;19(3):210-16. DOI: 10.1111/j.1365-2230.1994.tb01167.x. PMID: 8033378.
Lilly E, Lu PD, Borovicka JH, et al. Development and validation of a vitiligo-specific quality-of-life instrument (VitiQoL). J Am Acad Dermatol. 2013;69(1):e11-e18. DOI: 10.1016/j.jaad.2012.01.038. PMID: 22365883.
Ezzedine K, Ahmed M, Tovar-Garza A, et al. Cross-cultural validation of a short-form of the Vitiligo Impact Patient scale (VIPs). J Am Acad Dermatol. 2019;81(5):1107-1114. DOI: 10.1016/j.jaad.2019.02.008. PMID: 30763647.
Bae JM, Oh SH, Kang HY, et al. Development and validation of the Vitiligo Extent Score for a Target Area (VESTA) to assess the treatment response of a target lesion. Pigment Cell Melanoma Res. 2019;32(2):315-319. DOI: 10.1111/pcmr.12730. PMID: 30117287.
Peralta-Pedrero ML, Morales-Sánchez MA, Jurado-Santa Cruz F, De la Torre-García ME, Cruz-Peralta ES, Olguín-García MG. Systematic Review of Clinimetric Instruments to determine the severity of Non-segmental Vitiligo. Australas J Dermatol. 2019;60(3):e178-e85. DOI: 10.1111/ajd.13008. PMID: 30820942.
van Geel N, Depaepe L, Vandaele V, Mertens L, Van Causenbroeck J, De Schepper S, et al. Assessing the dynamic changes in vitiligo: reliability and validity of the Vitiligo Disease Activity Score (VDAS) and Vitiligo Disease Improvement Score (VDIS). J Eur Acad Dermatol Venereol. 2022;36(8):1334-1341. DOI: 10.1111/jdv.18134. PMID: 35398942.
Lee JH, Ju HJ, Seo JM, et al. Comorbidities in Patients with Vitiligo: A Systematic Review and Meta-Analysis. J Invest Dermatol. 2023;143(5):777-789.e6. DOI:10.1016/j.jid.2022.10.021. PMID: 36574529.
Spritz RA, Santorico SA. The Genetic Basis of Vitiligo. J Invest Dermatol. 2021;141(2):265-273. DOI: 10.1038/jid.2013.5. PMID: 23321921.
Hua C, Boussemart L, Mateus C, et al. Association of Vitiligo With Tumor Response in Patients With Metastatic Melanoma Treated With Pembrolizumab. JAMA Dermatol. 2016;152(1):45-51. DOI: 10.1001/jamadermatol.2015.2707. PMID: 26501224.
Chang WL, Ko CH. The Role of Oxidative Stress in Vitiligo: An Update on Its Pathogenesis and Therapeutic Implications. Cells. 2023;12(6). DOI:10.3390/cells12060936. PMID: 36980277.
Ezzedine K, Eleftheriadou V, Whitton M, van Geel N. Vitiligo. Lancet. 2015;386(9988):74-84. DOI: 10.1016/S0140-6736(14)60763-7. PMID: 25596811.
Frisoli ML, Essien K, Harris JE. Vitiligo: Mechanisms of Pathogenesis and Treatment. Annu Rev Immunol. 2020;38:621-648. DOI: 10.1146/annurev-immunol-100919-023531. PMID: 32017656.
Grootjans J, Kaser A, Kaufman RJ, Blumberg RS. The unfolded protein response in immunity and inflammation. Nat Rev Immunol. 2016;16(8):469-484. DOI: 10.1038/nri.2016.62. PMID: 27346803.
Li S, Zhu G, Yang Y, et al. Oxidative stress drives CD8+ T-cell skin trafficking in patients with vitiligo through CXCL16 upregulation by activating the unfolded protein response in keratinocytes. J Allergy Clin Immunol. 2017;140(1):177-189. DOI: 10.1016/j.jaci.2016.10.013. PMID: 27826097.
Birlea SA, Goldstein NB, Norris DA. Repigmentation through Melanocyte Regeneration in Vitiligo. Dermatol Clin. 2017;35(2):205-218. DOI: 10.1016/j.det.2016.11.015. PMID: 28317529.
Lei T-C, Hearing VJ. Deciphering skin re-pigmentation patterns in vitiligo: an update on the cellular and molecular events involved. Chin Med J (Engl). 2020;133(10):1231-1238. DOI: 10.1097/CM9.0000000000000794. PMID: 32433056.
El-Domyati M, El-Din WH, Rezk AF, et al. Systemic CXCL10 is a predictive biomarker of vitiligo lesional skin infiltration, PUVA, NB-UVB and corticosteroid treatment response and outcome. Arch Dermatol Res. 2022;314(3):275-284. DOI:10.1007/s00403-021-02228-9. PMID: 33866437.
Bhatnagar A, Kanwar AJ, Parsad D, De D. Psoralen and ultraviolet A and narrow-band ultraviolet B in inducing stability in vitiligo, assessed by vitiligo disease activity score: an open prospective comparative study. J Eur Acad Dermatol Venereol. 2007;21(10):1381-1385. DOI:10.1111/j.1468-3083.2007.02283.x. PMID: 17958845.
Rodrigues M, Ezzedine K, Hamzavi I, Pandya AG, Harris JE. Current and emerging treatments for vitiligo. J Am Acad Dermatol. 2017;77(1):17-29. PMID: 28619557. DOI: 10.1016/j.jaad.2016.11.010. PMID: 28619557.
Nicolaidou E, Antoniou C, Stratigos A, Katsambas AD. Narrowband ultraviolet B phototherapy and 308-nm excimer laser in the treatment of vitiligo: a review. J Am Acad Dermatol. 2009;60(3):470-477. DOI: 10.1016/j.jaad.2008.07.053. PMID: 19157641.
Kim HJ, Hong ES, Cho SH, Lee JD, Kim HS. Fractional Carbon Dioxide Laser as an "Add-on" Treatment for Vitiligo: A Meta-analysis with Systematic Review. Acta Derm Venereol. 2018;98(2):180-184. DOI: 10.2340/00015555-2836. PMID: 29110015.
Pazyar N, Hatami M, Yaghoobi R, Parvar SY, Radmanesh M, Hadibarhaghtalab M. The efficacy of adding topical 5-fluorouracil to micro-needling in the treatment of vitiligo: A randomized controlled trial. J Cosmet Dermatol. 2023;22(5):1513-1520. DOI:10.1111/jocd.15616. PMID: 36718813.
Wang Z, Feng C, Chang G, Liu H, Li S. The use of platelet-rich plasma in wound healing and vitiligo: A systematic review and meta-analysis. Skin Res Technol. 2023;29(9):e13444. DOI:10.1111/srt.13444. PMID: 37753680
Downloads
Published
Issue
Section
License
Copyright (c) 2024 Yaqing Wen, Li Lei, Ling Jiang, Chuhan Fu, Shu Zhou, Keyi Zhang, Jiangfeng Huang, Jing Chen, Qinghai Zeng
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
Dermatology Practical & Conceptual applies a Creative Commons Attribution License (CCAL) to all works we publish (http://creativecommons.org/licenses/by-nc/4.0/). Authors retain the copyright for their published work.